Skip to main content
Clinical Trials/NCT01204554
NCT01204554
Unknown
Early Phase 1

Microcirculation in Perforator Flaps. Enhancing Tissue Survival

Oslo University Hospital1 site in 1 country50 target enrollmentSeptember 2008

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Reconstructive Surgery
Sponsor
Oslo University Hospital
Enrollment
50
Locations
1
Primary Endpoint
Mean pixel intensity using dynamic laser-induced-fluorescence-videoangiography
Last Updated
15 years ago

Overview

Brief Summary

The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.

Detailed Description

Perforator flaps are increasingly used in reconstructive surgery both as pedicled and free flaps, mostly because of reduced donor site morbidity and superior aesthetic result. However, the there is still much to learn about the hemodynamic changes within these flaps.The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.

Registry
clinicaltrials.gov
Start Date
September 2008
End Date
December 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • patients submitted to elective abdominoplasty

Exclusion Criteria

  • body mass index \< 30 kg/m2
  • morbidly obese
  • patients with comorbidity such as diabetes
  • vascular disease
  • patients \< 18 years, and patients using anti-coagulant therapy
  • severe hepatic insufficiency were excluded and a history of allergic reactions to ICG and iodide.

Outcomes

Primary Outcomes

Mean pixel intensity using dynamic laser-induced-fluorescence-videoangiography

Time Frame: dec. 2008--des 2010

Perfusion measurements were conducted intraoperatively by assessing microcirculation using the technique of dynamic laser-induced-fluorescence-videoangiography (IC-VIEW, PULSION Medical Systems AG, Munich, Germany).

Study Sites (1)

Loading locations...

Similar Trials